De novo expression of vascular endothelial growth factor in human pancreatic cancer: Evidence for an autocrine mitogenic loop

Gastroenterology

Volumn 119, Issue 5, 2000, Pages 1358-1372

  Von Marschall, Zofia ^a   Cramer, Thorsten ^b   Höcker, Michael ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; GROWTH FACTOR RECEPTOR; LYMPHOKINE; ONCOPROTEIN; PROTEIN TYROSINE KINASE; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1;

ADENOCARCINOMA; ARTICLE; AUTOCRINE EFFECT; CELL CULTURE; CELL DIVISION; DRUG EFFECT; HUMAN; METABOLISM; MITOSIS; PANCREAS TUMOR; PATHOLOGY;

ADENOCARCINOMA; AUTOCRINE COMMUNICATION; CELL DIVISION; ENDOTHELIAL GROWTH FACTORS; HUMANS; LYMPHOKINES; MITOSIS; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034323062     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2000.19578     Document Type: Article

References (57)

1. Murr MM, Starr MG, Oishi AJ, van Heerden JA. Pancreatic cancer. Ça Cancer J Clin 1994;44:304-318.
2. American Cancer Society. Cancer Facts and Figures 1991. Atlanta, GA: American Cancer Society, 1991.
3. Rosewicz S, Wiedenmann B. Pancreatic carcinoma. Lancet 1997; 349:485-489.
4. Folkman J, Watson K, Ingber, D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989;339:58-61.
5. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
6. Folkman J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 1995;333:1757-1763.
7. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353364.
8. Ferrara N, Heinsohn H, Walder CE, Bunting S, Thomas GR. The regulation of blood vessel growth by vascular endothelial growth factor. Ann NY Acad Sei 1995;752:246-256.
9. Ferrara N. The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res Treat 1995;36:127137.
10. Kolch W, Martiny-Baron G, Kieser A, Marmé D. Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis. Breast Cancer Res Treat 1995;36:139-155.
11. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-1309.
12. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW. The vascular endothelial growth factor family: identification of fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 1991;5:1806-1814.
13. Tischer E, Mitchell R, Hartmann T, Suva M, Gospodarowicz D, Fiddes J, Abraham J. The human gene for vascular endothelial growth factor. J Biol Chem 1991; 266:11947-11954.
14. Poltorak Z, Cohen T, Sivan R, Kandelis Y, Spira G, Vlodavsky I, Keshet E, Neufeld G. VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J Biol Chem 1997;272:7151-7158.
15. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 1992;267: 26031-26037.
16. Rak J, Mitsuhashi Y, Bayko L, Filmus J, Shirasawa S, Sasazuki T, Kerbel RS. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res 1995:55:4575-4580.
17. Kieser A, Weich HA, Brandner G, Marme D, Kolch W. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 1994;9:963-969.
18. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843-845.
19. Ikeda E, Achen MG, Breier G, Risau W. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 1995;34: 19761-19766.
20. De Vries C, Escobedo JA, Ueno H, Houck KA, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992:255:989-991.
21. Terman Bl, Dougher-Vermazen MD, Carrion ME, Dimitrov D, Ar-mellino DC, Gospodaroi/vicz D, Böhlem P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 1992:187:15791586.
22. Matthews W, Jordan CI", Gavin M, Jenkins NA, Copeland NG, Lemischka IR. A receptor tyrosine kinase cDNA isolated from a population of enriched Dhmitive hematopoetic cells and exhibiting close genetic linkage to c-kit. Proc Natl Acad Sei U S A 1991;88:9026-9030.
23. Quinn T, Peters KG, deVries C, Ferrara N, Williams LT. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressec in vascular endothelium. Proc Natl Acad Sei U S A 1993:90:7533-7537.
24. Barleon B, Hauser S, Schumann C, Weindel K, Marmé D, Yayon A, Weich HA. Différentiel expression of the two VEGF receptors fit and KDR in placenta and vascular endothelial cells. J Cell Biochem 1994:54:56-66
25. Breier G, Clauss M, Ris au W. Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development. Dev Dyn 1995:204:228-239.
26. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NP, Risau W, Ullrich A High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993:72:835-846.
27. Waltenberger J, Claess on-Welsh L, Siegbahn A, Shibuya M, Heldin CH. Different signa1 transduction properties of KDR and Flt-1, two receptors for vascular endothelial growth factor. J Biol Chem 1994:269:26988-26995.
28. Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, Shibuya M. A unique signal tiansduction from FIT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene 1995:10:135-147.
29. Brown LF, Berse B, lackman RW, Tognazzi K, Manseau EJ, Dvorak HF, Senger DR Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 1993:143: 1255-1262.
30. Brown LF, Berse B, JaDkman RW, Tognazzi K, Manseau EJ, Senger DR, Dvorak HF. Expression of vascular permeability factor (vascular endothelial t'rowth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 1993:53: 4727-4735.
31. Takahashi Y, Kitadai N, Bucana CD, Cleary KR, Ellis, LM. Expression of vascular endolhelial growth factor and its receptor, KDR, correlates with vascu arity, metastasis, and proliferation of human colon cancer. Cancer Res 1995:55:3964-3968.
32. Plate KH, Breier G, \Veich HA, Risau W. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature 1992:359:845-848.
33. Kondo S, Asano M, Sizuki H. Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody. Biochem Biophys Res Commun 1993:194:1234-1241.
34. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 1993;362: 841-844.
35. Millauer B, Shawver .K, Plate KH, Risau W, Ullrich A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 1994:367:576-579.
36. Millauer B, Longhi MF1, Plate KH, Shawver LK. Risau W, Ullrich A, Strawn LM. Dominani-negative inhibition of Flk-1 suppresses the growth of many tumo ' types in vivo. Cancer Res 1996:56:16151620.
37. Itakura J, Ishiwata T, rriess H, Fujii H, Matsumoto Y, Büchler MW, Korc M. Enhanced impression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression. Clin Cancer Res 1997:3:1309-1316.
38. Ellis LM, Takahashi Y, Fenoglio CJ, Cleary KR, Bucana CD, Evans DB. Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma. Eur J Cancer 1998:34:337340.
39. Egawa SI, Tsutsumi M, Konishi Y, Kobari M, Matsuno S, Nagasaki K, Futami H, Yamaguchi K. The role of angiogenesis in the tumor growth of Syrian hamster pancreatic cancer cell line HPDNR. Gastroenterology 1995:108:1526-1533.
40. Klöppel G. Pathology of nonendocrine tumors. In: Go VLW, DiMagno EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA, eds. The pancreas. New York: Raven, 1993:871-897.
41. Matthes H, Kaiser A, Stier U, Riecken EO, Rosewicz S. Glucocorticoid receptor gene expression in the exocrine and endocrine rat pancreas. Endocrinology 1994;135:476-479.
42. Suzuki K, Hayashi N, Miyamoto Y, Yamamoto M, Ohkawa K, Ito Y, Sasaki Y, Yamaguchi Y, Nakase H, Noda K, Enomoto N, Aral K, Yamada Y, Yoshihara H, Tujirnura T, Kawano K, Yoshikawa K, Kamada T. Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma. Cancer Res 1996;56:3004-3009.
43. Bikfalvi A, Sauzeau C, Moukadiri H, Maclouf J, Busso N, Bryckaert M, Plouet J, Tobelem G. Interaction of vasculotropin/vascular endothelial growth factor with human umbilical vein endothelial cells: binding, internalization, degradation, and biological effects. J Cell Physiol 1991:149:50-59.
44. D'AngeloG, Struman I, Martial J, Weiner RI. Activation of mitogenactivated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin. Proc Natl Acad Sei U S A 1995:92:6374-6378.
45. Marais R, Wynne J, Treisman R. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 1993:73:381-393.
46. Rooman I, Schuit F, Bouwens L. Effect of vascular endothelial growth factor on growth and differentiation of pancreatic ductal epithelium. Lab Invest 1997:76:225-232.
47. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988:53:549-554.
48. Konishi Y, Tsutsumi M, Tsujiuchi T. Mechanistic analysis of pancreatic ductal carcinogenesis in hamsters. Pancreas 1998; 16:300-306.
49. Kalthoff H, Schmiegel W, Roeder C, Kasche D, Schmidt A, Lauer G, Thiele HG, Honold G, Pantel K, Riethmuller G, Scherer E, Maurer J, Maacke H, Deppert W. p53 and K-RAS alterations in pancreatic epithelial cell lesions. Oncogene 1993;8:289-298.
50. Goldman CK, Kim J, Wong WL, King V, Brock T, Gillespie GY. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol Biol Cell 1993:4: 121-133.
51. Finkenzeller G, Marme D, Weich HA, Hug H. Platelet-derived growth factor-induced transcription of the vascular endothelial growth factor gene is meditated by protein kinase C. Cancer Res 1992:52:4821-4823.
52. Pertovaara L, Kaipainen A, Mustonen T, Orpana A, Ferrara N, Saksela 0, Alitalo K. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem 1994;269:6271-6274.
53. Friess H, Berberat P, Schilling M, Kunz J, Köre M, Büchler MW. Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors. J Mol Med 1996:74: 35-42.
54. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marmé D. Migration of human monocytes in response to vascular endothe-liai growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 1996;87:3336-3343.
55. Boocock CA, Charnock-Jones S, Sharkey AM, McLaren J, Barker PJ, Wright KA, Twentyman PR, Smith SK. Expression of vascular endothelial growth factor and its receptors fit and KDR in ovarian carcinoma. J Natl Cancer Inst 1995:7:506-516.
56. Gitay-Goren H, Halaban R, Neufeld G. Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors. Biochem Biophys Res Commun 1993:190: 702-708.
57. Itakura J, Ishiwata T, Shen B, Kornmann M, Köre M. Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer. Int J Cancer 2000;85:27-34.